Provided by Tiger Fintech (Singapore) Pte. Ltd.

Blue Water Acquisition Corp.

9.63
0.0000
Volume:- -
Turnover:- -
Market Cap:69.77M
PE:9.82
High:9.63
Open:9.63
Low:9.63
Close:9.63
Loading ...

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:45 PM

Reuters
·
09 Sep 2021

Mid-Morning Market Update: Markets Mixed; Dollar General Profit Beats Views

Benzinga
·
26 Aug 2021

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:36 AM

Reuters
·
26 Aug 2021

Blue Water Acquisition Corp. Announces Date for Special Meeting of Stockholders to Vote on Transaction With Clarus Therapeutics, Inc.

StreetInsider
·
30 Jul 2021

BRIEF-Clarus Therapeutics - Co, Havah Therapeutics Announced Licensing Agreement

Reuters
·
25 May 2021

Clarus Therapeutics And HavaH Therapeutics Announce Licensing Agreement For Product To Treat Androgen-Dependent Inflammatory Breast Disease And Certain Forms Of Breast Cancer

PR Newswire
·
25 May 2021

Lifshitz Law Firm, P.C. Announces Investigation of BLUW, GMII, MRAC, PEBO, PFBI SEAH, DEH, FWAA, MTSL, and DBDR

PR Newswire
·
12 May 2021

NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: Gores Metropoulos II, Inc. (Nasdaq - GMII), Marquee Raine Acquisition Corp. (Nasdaq - MRAC), Blue Water Acquisition Corp. (Nasdaq - BLUW)

ACCESSWIRE
·
04 May 2021

Moore Kuehn Encourages LEAF, SEAH, HGV, and BLUW Investors to Contact Law Firm

PR Newswire
·
04 May 2021

INVESTIGATION ALERT: Halper Sadeh LLP Investigates BLUW, SEAH, FWAA, DBDR, DEH; Shareholders are Encouraged to Contact the Firm

PR Newswire
·
29 Apr 2021

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Blue Water Acquisition Corp. (Nasdaq – BLUW)

ACCESSWIRE
·
28 Apr 2021

Blue Water Acquisition Corporation Announces Merger Agreement with Clarus Therapeutics, Forming A Publicly Listed Company To Address Unmet Needs Of Men And Women Through Development Of Androgen And Metabolic Therapies

PR Newswire
·
27 Apr 2021